- 5-Star Manager's 5 Top Stocks
- Art Cashin: The S&P's 'Head and Shoulders' Number
- Go for Good Energy Companies: Bob Doll
- Five Stock Picks for This Market
- Weak Dollar Means Gold at $1,040: Strategist
- Art Cashin Sees 11% Unemployment, Market 'Stagnation'
- Najarian: Options Bet on July Akamai Pop
- London Mover: LSE Group
- Oil Outlook for the Second Half
- Stock Strategies for the '7th Inning'
- Brandt: Bing, The Little Search Engine That Couldn't
- 5-Star Manager's 5 Top Stocks
- Hey, What's Up Doc?
- Busch: Summertime Blues Hits Investors
- Chadwick: Recession and Scandals Pave the Way for Romney 2012
- Art Cashin: The S&P's 'Head and Shoulders' Number
- Michael Jackson: Death And Taxes
- Is Andy’s Mojo Back? We Asked Him
- GM A Step Closer To Exiting Bankruptcy
- Goldman Sees No Harm From Computer Programmer
- Justice Dept Said to Be Looking At Telecom Giants
- Lehman CEO: Firm Deserved Bailout or 'Wind Down'
- GM to Get Final $20 Billlion From US This Year
- Recession Special: Wine Cheaper Than Water!
- Facebook Director Sees 'Billions' in Revenue in 5 Years
- Jackson's Mom Asks to Manage Son's Estate
- Judge Gives Control of Jackson Estate to Executors
- The Weirdest Currencies in The World
RSS FEED

Gabe Hilmoe is getting an early start on the stock market. He's portfolio manager of the Henry Fund at the University of Iowa, and he's got some strong ideas about equity investments.
The Henry Fund, like many student-run investment vehicles, operates with real money, and the 12 MBA students who run it currently handle about $1.5 million. Hilmoe specializes in the health-care side of the portfolio.
Recommendations:
"Right now, we still like Genentech [DNA
Loading...
()
]," he told CNBC. "We still see more upside, with another Roche bid coming in."
It's not just biotech that he likes; in the medical device field, he's enthusiastic about Stryker [SYK
Loading...
()
].
"It's definitely a growth story," he said. "We see a huge upside in terms of a demographic trend: A lot more people are getting orthopedic surgery, and it's becoming more popular with a younger population as well."
Hilmoe has a pick outside health care as well: Sherwin Williams [SHW
Loading...
()
], a seemingly contrarian play because its best-known product, paint, is so closely tied to housing.
"The idea is that less than 10 percent of their revenues are tied to new residential construction," he explained. "We see a lot of opportunity in emerging markets and...it has room to grow."
________________________
NEW!
________________________
Disclosures:
Disclosure information for Gabe Hilmoe was not immediately available.







